Ontario Neurotrauma Foundation Report issue

Foundation Phase 2 Phase 3 Phase 4
Founded: Toronto Canada (1998)

Organization Overview

First Clinical Trial
2000
NCT00150696
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Ontario Neurotrauma Foundation